The following data is part of a premarket notification filed by Princeton Biomeditech Corp. with the FDA for Accusign Bzo, Biosign Bzo, Status Bzo.
| Device ID | K991079 |
| 510k Number | K991079 |
| Device Name: | ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO |
| Classification | Enzyme Immunoassay, Benzodiazepine |
| Applicant | PRINCETON BIOMEDITECH CORP. 4242 U.S. ROUTE 1 P.O. BOX 7139 Monmouth Junction, NJ 08852 -1905 |
| Contact | Jemo Kang |
| Correspondent | Jemo Kang PRINCETON BIOMEDITECH CORP. 4242 U.S. ROUTE 1 P.O. BOX 7139 Monmouth Junction, NJ 08852 -1905 |
| Product Code | JXM |
| CFR Regulation Number | 862.3170 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Special |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1999-03-26 |
| Decision Date | 1999-04-15 |